Diasol 100220-10100
Diasol 100220-10100 (ACD21-ACG50) is a haemodialysis concentrate (FDA Class II; FDA product code KPO, Dialysate Concentrate For Hemodialysis (Liquid Or Powder)) made by Diasol Inc, cleared under FDA 510(k) K851431 on 12 Jun 1985 and listed in FDA GUDID since 8 Feb 2017 (UDI-DI B46710022010100), active as of 23 Oct 2026. 8 FDA recalls are linked to it.
Active
Valid until
No expiry
FDA recalls
7 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | NumberB46710022010100 | Date8 Feb 2017 | StatusListed |
| United States | FDA 510(k)SESE | NumberK851431 | Date12 Jun 1985 | StatusActive |
Official records
- FDA 510(k) database K851431
From the FDA record
- Device description
- Diasol Liquid Acid Concentrate for Bicarbonate Dialysis
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K851431 decided 12 Jun 1985 Active
- FDA GUDID UDI-DI B46710022010100 listed 8 Feb 2017 Listed
Recalls
-
- Ongoing Z-0991-2026
- Ongoing Z-0992-2026
- Ongoing Z-0989-2026
- Ongoing Z-0990-2026
- Ongoing Z-0987-2026
- Ongoing Z-0988-2026
Safety and efficacy of dialysis acid concentrate cannot be assured
-
- Ongoing Z-0207-2025
Due to labeling issue. The box label is different that the gallon label in that gallon label shows a lower Calcium concentration than the box label.
-
- Terminated Z-2402-2020
Incorrect labeling of dialysate concentration for hemodialysis.
Timeline
- Cleared FDA 510(k) K851431
- Listed FDA GUDID B46710022010100
- Recall initiated FDA recalls Z-2402-2020
- Recall initiated FDA recalls Z-0207-2025
- Recall initiated FDA recalls Z-0991-2026
- Recall initiated FDA recalls Z-0992-2026
- Recall initiated FDA recalls Z-0989-2026
- Recall initiated FDA recalls Z-0990-2026
- Recall initiated FDA recalls Z-0987-2026
- Recall initiated FDA recalls Z-0988-2026
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Diasol
- Generic name
- Haemodialysis concentrate
- Model / Ref / Catalog
- 100220-10100, ACD21-ACG50
- Primary DI / UDI-DI
- B46710022010100
- 510(k) Number
- FDA product code
- KPO
- GMDN term
- Haemodialysis concentrate
- Device class
- Class II
- Regulation number
- 876.5820
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)).
- HEMODIALYSIS CONCENTRATE SOLUTION by Mid Atlantic Nephrology Center
- DRYALYSATE CONCENTRATE by Advanced Renal Technologies, Inc.
- CHEM-DIALYTE CONCENTRATES by Luchem Pharmaceuticals, Inc.
- HOSPAL DIALYSATE FOR C.A.V.H.D. by Delmed, Inc.
- HEMODIALYSIS BATH CONCENTRATE SOLUTIONS FOR HEMODI by Dial Medical of Florida, Inc.
- DIALYSIS CONCENTRATE by Diversified Medical Services
- Citric Complete Dry Citric Acid (45X) by DIMESOL USA, LLC
- ROCKWELL MEDICAL SUPPLY, LLC. CONCENTRATE SOLUTIONS FOR ACETATE DIALYSATE by International Medical Products, Inc.
- Hemo-Lyte C Cartridge by Di-Chem, Inc.
- DRY AC ACID CONCENTRATE MIX FOR BICARBONATE HEMODIALYSIS by Gambro Renal Products, Inc.